Multiple Myeloma (MM)

Antibody Recruiting Molecule BHV-1100 with Autologous Memory-like Natural Killer Cell Therapy Plus Intravenous Immunoglobulin, Followed by Low-Dose IL-2 in Multiple Myeloma Patients in the Peri-autologous Stem Cell Transplant Setting

Resources

Biohaven is committed to serving people who suffer from MM, and the MM community at large. That’s why we are not only working with MM doctors and researchers to develop a potential new treatment medication, but also to support MM advocacy and provide a wide variety of easily accessible resources. We hope you find value in the information below.

Multiple Myeloma Research Foundation (MMRF)

The Multiple Myeloma Research Foundation (MMRF) drives discoveries for new treatments, accelerates groundbreaking clinical trials and fuels the most robust data-driven initiatives in cancer research. Our goal is to find a cure for each and every patient diagnosed with multiple myeloma.